genomic landscape of late-stage gastric cancer treated with pembrolizumab
Published 2 years ago • 349 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
4:35
keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
-
1:04
panthera: pembrolizumab, trastuzumab, and chemotherapy in her2 advanced gastric cancer
-
3:15
pembrolizumab demonstrates promise in patients with pretreated metastatic gastric cancer
-
0:54
perioperative pembrolizumab for stomach cancer treatment
-
3:01
treating patients with gastric cancer with immunotherapy: who will benefit?
-
0:59
the future treatment landscape of gastric cancer
-
50:43
genetics, genomics, and epidemiology of gastric cancer in diverse patient populations
-
51:23
a novel approach to the treatment of iga nephropathy
-
29:14
keynote lecture 3: carcinogenesis and molecular events in gastric cancer
-
6:52
prognostic value of body weight loss in previously treated metastatic gastric cancer
-
23:04
carcinogenesis of gastric cancer through the eyes of a pathologist
-
42:54
gastric cancer: the era of genomics and targeted therapy
-
5:40
advanced/metastatic gastric cancer: beyond frontline
-
7:06
north shore 5th grader becomes third person in family diagnosed with rare stomach cancer
-
8:17
metastatic gastric cancer: indications and impact of targeting the her2 pathway?
-
18:09
are all gastric cancers identical? - dr. manish shah
-
2:26
interim results for gastric cancer treatment with ramucirumab plus pembrolizumab
-
1:00:13
educated patient® webinars: stomach cancer 101 series: part i – diagnosis and staging
-
47:26
treating stomach and gastrointestinal cancers with immunotherapy